Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 
Guidelines | 2023
Overdose, Clinical guidance

Fueled by misinformation, fentanyl panic has harmed public health through complicating overdose rescue while rationalizing hyper-punitive criminal laws, wasteful expenditures, and proposals to curt

Original research | 2020
Overdose, Evidence base, Advocacy, Barriers and enablers
Commentary | 2017
Harm reduction, Policy/Regulatory
Letter | 2018
Chronic pain, About prescribers, Advocacy, Policy/Regulatory
Lit review | 2023
Housing
Commentary | 2023
Clinical guidance, Harm reduction, Wrap-around services, About PWUD

We sought to examine changes in health service use and incident cases of psychotic disorder following cannabis legalization, during a period of tight restrictions on retail stores and product types

Original research | 2023
Decriminalization/legalization, Outcomes, Hospitals, Mental health

Opioid overdose is the second leading cause of accidental death. Safe Consumption Sites (SCSs) are very effective harm reduction, but skepticism persists in the U.S. In four U.S.

Original research | 2023
SCS/OPS, Hesitancy of prescribers , Advocacy
Report | 2023
Mortality, Overdose, Policy/Regulatory, Safer supply, Decriminalization/legalization

This study aims to provide evidence of factors that impact participant reported serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT).

Original research | 2023
About PWUD, Mental health

To assess the associations of RAAM clinics with emergency department (ED) visits, hospitalizations, and mortality for people with problematic opioid use (POU).

Original research | 2023
Substitution/OAT, About PWUD, Mortality, Hospitals
Commentary | 2023
Evidence base, Policy/Regulatory, Hesitancy of prescribers , Equity
Report | 2023
Safer supply, Evidence base, Wrap-around services, Social services, Barriers and enablers

The Kitchener-Waterloo Safer Supply Program (SSP) opened in 2021 with funding from Health Canada’s Substance Use and Addiction Program, as one of the time-limited pilot programs that offers differe

Report | 2023
Safer supply, Evidence base, Housing, Poverty, Social benefits, Wrap-around services, Social services

This study aimed to understand the emergency department (ED) healthcare experiences of people who use substances (PWUS) with the intent of informing ways of improving the delivery of equitable care

Original research | 2023
About PWUD, About prescribers, Stigma, Hospitals
Case study | 2023
Chronic pain, Substitution/OAT, About PWUD, About prescribers

The aim of this study was to examine expert views on the effectiveness and implementability of state policies to improve engagement and retention in treatment for opioid use disorder (OUD).

Original research | 2023
About prescribers, Policy/Regulatory, Harm reduction

The objective of this analysis was to compare the efficacy and safety of 100-mg versus 300-mg maintenance doses of BUP-XR in OUD patients who inject opioids.

Original research | 2023
Substitution/OAT, Outcomes, About PWUD

To align with a person-centered care approach, iOAT can be embedded in sites that combine systems and services that have been historically fragmented and that address multiple comorbidities (integr

Original research | 2023
Wrap-around services

Refine Your Search

Keywords
Format
Region